Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dave Spellman

Dave Spellman is recorded as CFO at Akebia Therapeutics, Inc. (AKBA). Dave Spellman has spoken on 2 earnings calls across 1 company, most recently for Akebia Therapeutics, Inc. on May 8, 2023.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Akebia Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.